Clinical trial
Treatment for Patients With Osteoarthritis (OA)
NCT00110942 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00110942 |
|---|---|
| Title | Treatment for Patients With Osteoarthritis (OA) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Systemic AMG 108 in Subjects With Osteoarthritis (OA) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug, Other |
| Interventions | Systemic AMG 108, Placebo |
| Enrollment | 160 |
| Start date | Feb 1, 2005 |
| Primary completion | Jun 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | May 17, 2005 |
| Last update posted | Jun 23, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: